ストックスクリーナーアプリを入手
252.43
0.93%
2.33
アフターアワーズ：
252.43
前日終値:
$250.10
開ける：
$250.25
24時間の取引高:
1.32M
Relative Volume:
1.26
時価総額：
$36.96B
収益：
$5.26B
当期純損益:
$1.44B
株価収益率:
25.83
EPS:
9.7713
ネットキャッシュフロー:
$1.76B
1週間 パフォーマンス:
+2.45%
1か月 パフォーマンス:
-7.19%
6か月 パフォーマンス:
+3.02%
1年 パフォーマンス:
+1.50%
1日の値動き範囲:
$248.16
$254.75
1週間の範囲:
$241.62
$254.75
52週間の値動き範囲:
$199.92
$293.81
Resmed Inc Stock (RMD) Company Profile
RMD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
252.43 | 36.51B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
ISRG
Intuitive Surgical Inc
|
572.17 | 204.26B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
189.02 | 52.06B | 21.84B | 1.68B | 2.55B | 5.8322 |
|
ALC
Alcon Inc
|
77.36 | 36.78B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
277.41 | 19.82B | 2.96B | 487.70M | 344.00M | 6.6758 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-18 | 開始されました | Citigroup | Buy |
| 2025-09-02 | アップグレード | CLSA | Hold → Outperform |
| 2025-07-15 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-19 | 開始されました | Morgan Stanley | Overweight |
| 2025-01-16 | 開始されました | Goldman | Buy |
| 2025-01-10 | 開始されました | Piper Sandler | Neutral |
| 2024-12-13 | 開始されました | Stifel | Hold |
| 2024-09-24 | 開始されました | Robert W. Baird | Outperform |
| 2024-09-18 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | ダウングレード | Needham | Buy → Hold |
| 2024-06-25 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-06-24 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-02-06 | 再開されました | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-09-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | アップグレード | Needham | Hold → Buy |
| 2023-09-05 | ダウングレード | UBS | Buy → Neutral |
| 2023-08-01 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | 開始されました | UBS | Buy |
| 2023-04-14 | 開始されました | Mizuho | Buy |
| 2023-01-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-10-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-20 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-09-08 | アップグレード | Citigroup | Neutral → Buy |
| 2022-08-15 | ダウングレード | CLSA | Buy → Outperform |
| 2022-08-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-08-12 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-08-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-01-31 | アップグレード | Citigroup | Neutral → Buy |
| 2022-01-31 | アップグレード | Goldman | Neutral → Buy |
| 2022-01-28 | アップグレード | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-01-24 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-01-13 | アップグレード | CLSA | Outperform → Buy |
| 2022-01-13 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | アップグレード | Macquarie | Neutral → Outperform |
| 2021-10-22 | アップグレード | CLSA | Underperform → Outperform |
| 2021-08-02 | ダウングレード | CLSA | Outperform → Sell |
| 2021-08-02 | ダウングレード | Needham | Buy → Hold |
| 2021-07-28 | アップグレード | Jefferies | Underperform → Hold |
| 2021-07-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-07-14 | 開始されました | RBC Capital Mkts | Underperform |
| 2021-06-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-06-22 | アップグレード | Macquarie | Neutral → Outperform |
| 2021-06-22 | 開始されました | Robert W. Baird | Neutral |
| 2021-06-21 | 繰り返されました | Needham | Buy |
| 2021-06-16 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-06-09 | アップグレード | CLSA | Sell → Outperform |
| 2021-05-21 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-05-11 | アップグレード | Citigroup | Neutral → Buy |
| 2021-04-30 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-03-16 | アップグレード | Needham | Hold → Buy |
| 2020-11-02 | アップグレード | UBS | Neutral → Buy |
| 2020-10-30 | アップグレード | JP Morgan | Underweight → Neutral |
| 2020-10-27 | アップグレード | BofA Securities | Underperform → Neutral |
| 2020-08-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-05-01 | アップグレード | Oppenheimer | Perform → Outperform |
| 2020-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | 開始されました | CLSA | Underperform |
| 2020-01-31 | ダウングレード | UBS | Buy → Neutral |
| 2020-01-10 | 開始されました | Oppenheimer | Perform |
| 2019-11-22 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | アップグレード | UBS | Neutral → Buy |
| 2019-07-16 | ダウングレード | UBS | Buy → Neutral |
| 2019-05-06 | アップグレード | UBS | Neutral → Buy |
| 2019-04-18 | アップグレード | JP Morgan | Underweight → Neutral |
| 2019-01-25 | ダウングレード | Goldman | Buy → Neutral |
| 2019-01-25 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2018-10-26 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | 開始されました | Goldman | Buy |
すべてを表示
Resmed Inc (RMD) 最新ニュース
ResMed (NYSE:RMD) CEO Michael Farrell Sells 8,011 Shares - MarketBeat
Is ResMed Inc. (Common Stock) (RMEA) stock nearing a technical breakoutVolume Spike & Free Risk Controlled Daily Trade Plans - newser.com
Is ResMed Inc. stock positioned for digital growth eraEntry Point & Expert Curated Trade Setup Alerts - newser.com
Ex-Dividend Reminder: UNITIL, American Water Works and ResMed - Nasdaq
How ResMed Inc. (Common Stock) (RMEA) stock trades after earningsTrade Exit Summary & Verified Short-Term Plans - newser.com
Can ResMed Inc. (Common Stock) (RMEA) stock attract analyst upgradesWeekly Profit Report & Detailed Earnings Play Strategies - newser.com
ResMed Inc. $RMD Shares Sold by Savant Capital LLC - MarketBeat
Will earnings trigger a reversal in ResMed Inc.July 2025 PreEarnings & Stepwise Trade Execution Plans - newser.com
Aviva PLC Has $23.10 Million Stock Position in ResMed Inc. $RMD - MarketBeat
Using RSI to spot recovery in ResMed Inc.July 2025 Gainers & Safe Entry Trade Signal Reports - newser.com
What makes ResMed Inc. stock appealing to growth investorsShort Setup & Long Hold Capital Preservation Plans - newser.com
Why this leading fundie is tipping ResMed shares for near-term gains - MSN
ResMed CEO Farrell sells $2m in stock on November 7 - Investing.com Canada
Published on: 2025-11-10 20:03:07 - newser.com
How to build a dashboard for ResMed Inc. stockJuly 2025 Drop Watch & Long Hold Capital Preservation Tips - newser.com
ResMed CEO Reports Changes in Stock Ownership - TipRanks
[Form 4] RESMED INC Insider Trading Activity - Stock Titan
Chmn Farrell Sells 8,011 ($2M) Of ResMed Inc [RMD] - TradingView
ResMed Inc. Announces Proposed Sale of Securities by Officer - TipRanks
Will ResMed Inc. (RME) stock profit from automation waveWeekly Gains Summary & Smart Money Movement Alerts - newser.com
Key resistance and support levels for ResMed Inc.Swing Trade & Reliable Trade Execution Plans - newser.com
Mitsubishi UFJ Asset Management Co. Ltd. Buys 15,251 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Inc. (RMD) Stock Forecasts - Yahoo Finance
Will ResMed Inc. stock benefit from mergersPortfolio Gains Report & Weekly Market Pulse Alerts - newser.com
22% Of This ResMed Insider's Holdings Were Sold - Yahoo Finance
Will ResMed Inc. (Common Stock) (RMEA) stock deliver stable dividendsMarket Activity Summary & Capital Protection Trade Alerts - newser.com
Connor Clark & Lunn Investment Management Ltd. Has $32.06 Million Holdings in ResMed Inc. $RMD - MarketBeat
Is ResMed Inc. (RME) stock a buy on weakness2025 Breakouts & Breakdowns & Trade Opportunity Analysis Reports - newser.com
Why ResMed Inc. stock benefits from AI revolutionWeekly Trend Recap & High Return Trade Opportunity Guides - newser.com
Will ResMed Inc. (Common Stock) (RMEA) stock see valuation expansionTake Profit & Risk Adjusted Buy and Sell Alerts - newser.com
ResMed Inc. (RMD) Stock forecasts - Yahoo Finance UK
Can swing trading help recover from ResMed Inc. lossesWeekly Profit Recap & Smart Allocation Stock Tips - newser.com
Los Angeles Capital Management LLC Sells 100,306 Shares of ResMed Inc. $RMD - MarketBeat
Published on: 2025-11-09 05:39:14 - newser.com
ResMed Inc. stock momentum explainedTrade Volume Summary & Safe Entry Zone Tips - newser.com
Resona Asset Management Co. Ltd. Has $12.65 Million Position in ResMed Inc. $RMD - MarketBeat
Crestwood Advisors Group LLC Makes New Investment in ResMed Inc. $RMD - MarketBeat
How ResMed Inc. (Common Stock) (RMEA) stock reacts to fiscal policiesJuly 2025 Movers & Daily Stock Trend Reports - newser.com
ResMed Inc. Files Quarterly Report, Affirms Market Position - MSN
ResMed Inc. (NYSE:RMD) Passed Our Checks, And It's About To Pay A US$0.60 Dividend - 富途牛牛
Horizon Investment Services LLC Raises Holdings in ResMed Inc. $RMD - MarketBeat
Twin Capital Management Inc. Acquires 2,219 Shares of ResMed Inc. $RMD - MarketBeat
Why analysts remain bullish on ResMed Inc. stockWeekly Trade Summary & Weekly High Return Forecasts - newser.com
Is ResMed Inc. reversing from oversold territory2025 Key Lessons & Safe Entry Trade Signal Reports - newser.com
[144] RESMED INC SEC Filing - Stock Titan
ResMed Inc. Officer Plans Sale of 3,000 Shares - MSN
ResMed Inc. Reports Strong Q1 Earnings Amid Growth Challenges - MSN
Is ResMed Inc. stock oversold or undervaluedJuly 2025 Patterns & Safe Entry Momentum Tips - newser.com
Sienna Gestion Grows Stake in ResMed Inc. $RMD - MarketBeat
Andra AP fonden Raises Stock Position in ResMed Inc. $RMD - MarketBeat
What to do if you’re stuck in ResMed Inc.Bond Market & Consistent Profit Trade Alerts - newser.com
Resmed Inc (RMD) 財務データ
収益
当期純利益
現金流量
EPS
3.99%
大文字化:
|
ボリューム (24 時間):